Australian court hands out gun-jumping fine

An Australian biotechnology company must pay a A$1.05 million (€660,387) penalty for signing an agreement to direct its customers to the company that was purchasing some of its assets before the deal actually completed, the country’s Federal Court has held.

Unlock unlimited access to all Global Competition Review content